Stefan Haak is an immunologist with a PhD and over 15 years of expertise in both academic and industrial settings, focusing on autoimmunity, inflammation, tissue immunity, and immune oncology. Currently, as VP of Translational Science at Macomics, Stefan leads innovative research initiatives and has previously served as Biology Lead at Pieris Pharmaceuticals and co-founded Mysthera Therapeutics. Stefan has held notable positions as Group Leader at the Technical University of Munich and the University of Zurich, and as a Postdoctoral Fellow at Columbia University. Throughout their career, they have been recognized as a "Serial Innovator," initiating and executing several novel drug discovery programs.
This person is not in the org chart
This person is not in any teams
This person is not in any offices